Evidence map›Paper›PMID 34073165›Full record

ArticleJournal of clinical medicine2021

Population-Level Prevalence, Bother, and Treatment Behavior for Urinary Incontinence in an Eastern European Country: Findings from the LUTS POLAND Study.

Mikolaj Przydacz, Marcin Chlosta, Piotr Chlosta

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mikolaj PrzydaczDepartment of Urology, Jagiellonian University Medical College, 30-688 Krakow, Poland.ORCID 0000-0002-7381-7420
Marcin ChlostaDepartment of Urology, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Piotr ChlostaDepartment of Urology, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Jagiellonian University · PL

Funding

Astellas Farma N/AClinical Research Centre at the Ludwik Rydygier Memorial Specialist Hospital in Krakow N/AFerring Pharmaceuticals N/AOrlen Foundation N/APolish Urological Association N/A
6 · The paper itself

Abstract

objectivesPopulation-level data are lacking for urinary incontinence (UI) in Central and Eastern European countries. Therefore, the objective of this study was to estimate the prevalence, bother, and behavior regarding treatment for UI in a population-representative group of Polish adults aged ≥ 40 years.

methodsData for this epidemiological study were derived from the larger LUTS POLAND project, in which a group of adults that typified the Polish population were surveyed, by telephone, about lower urinary tract symptoms. Respondents were classified by age, sex, and place of residence. UI was assessed with a standard protocol and established International Continence Society definitions.

resultsThe LUTS POLAND survey included 6005 completed interviews. The prevalence of UI was 14.6-25.4%; women reported a greater occurrence compared with men (

conclusionUrinary incontinence was prevalent and greatly bothersome among Polish adults aged ≥ 40 years. Consequently, UI had detrimental effects on quality of life. Nonetheless, most affected persons did not seek treatment. Therefore, we need to increase population awareness in Poland about UI and available treatment methods, and we need to ensure adequate allocation of government and healthcare system resources.

Indexed as

epidemiologyPolandpopulationurinary incontinence

Identifiers

PMID34073165
PMCPMC8199423
OpenAlexW3164823380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.